A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants

Clinical trial NCT07118878 · COMPLETED

Trial details

NCT number: NCT07118878
Sponsor: Agomab Spain S.L.U.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fibrostenotic Crohn's Disease

Start date: 2025-08-06
Primary completion: 2025-09-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.